Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.



Published on

Published in: Business, News & Politics
  • Be the first to comment


  1. 1. MARKET RESEARCH ON PHARMACEUTICALS IN INDIA Reference code: IRRMRRMAR11-03 Published On: 15Mar2011 India Malaysia Singapore #42, II Floor, 3, Jalan BP 3/17, 7500ª Beach Road Venkatarathinam Nagar, Bandar Bukit Puchonga, #08-313, the Plaza Adyar, Chennai. 47100 Puchong, Singapore 199591 Tamil Nadu, India Selangor Darul Ehsan, MalaysiaMarket Research on Indian Pharmaceutical @IRRThis profile is a licensed product and is not to be photocopied
  2. 2. PRESS RELEASE Pharmaceutical market worldwide is witnessing increased opportunities in the area of Bio Pharmaceuticals, Pharmacogenomics and the organic market. India is one of the fastest- growing pharmaceutical markets in the world, and its market size has nearly doubled since 2005, and also expected to reach US$ 20 billion by 2015. India is the third-largest market in the world in terms of volume and fourteenth in terms of value. The government began to encourage the growth of drug manufacturing companies in India in the 1960s, and the Patent Act in 1970 allowed the industry to become what it is today Pharma industry is mounting at a swift rate in India, while a hold back in the growth has been encountered in US. Our report “Pharmaceutical in India” forecast to 2020, Pharma (clinical) industry of India is estimated to increase at a CAGR during 2008 – 2011, nearly dual the global average. The forecast caters a understanding scrutinize Indian pharmaceutical market, covering its exports of pharmaceutical products, technical capability, cost efficiency, government support and clinical research. It also supplemented with figures. Statistical information is from 2000 – 2020 and analysis is conducted in US$ million.Market Research on Indian Pharmaceutical @IRR 2This profile is a licensed product and is not to be photocopied
  3. 3. REPORT HIGHLIGHTS AND FEATURES Report Highlights:  Market Volume and Forecast  Indian Market distribution of Key Competitors  Population and Epidemiological Statistics for the Indian Market  Pharmaceutical Market by Product Category  Profiles of Key Companies in India Report Features:  Market Analysis of Indian Pharmaceuticals Industry in 2005-2015  Growth Analysis of Pharmaceuticals Industry worldwide  Estimation of the involvement of Multinational Pharmaceuticals companies in the domestic pharmaceuticals market.  Growth Drivers-Technical capability, cost efficiency, government support.  Key trends –growing global demand for generics, launch of patented molecules, rural market opportunities.Market Research on Indian Pharmaceutical @IRR 3This profile is a licensed product and is not to be photocopied
  4. 4. CONTENTS India Advantage  India Advantages –vision 2011 Market Analysis  Market volume of the Indian pharmaceutical industry  Market segments-CRAMS, Formulations, API  Exports of pharmaceutical products  Growth Drivers on Technical capability  Growth Drivers on Cost Efficiency  Growth Drivers on Government support  Key trends for growing global demand for generics  Key trends for launch of patented molecules  Key trends for rural market opportunities  Key players-Leading Indian Players by Sales (US$ Billions) Industry Infrastructure  Various Special Economic Zones in India Investments  Cumulative FDI inflow November2000 to August 2010  M&A Scenario from January 2010-October 2010  Investments by acquirer Strategy and Regulatory outline  Strategy and Regulatory outline for Pharma industry  Central & State Government Policies  Measurement for Budget & Policy Scope  Indian Pharmaceuticals R&D Expenditure  Count on ANDA –US FDA approval  Outsourcing market in India  Market size forecast of Indian Clinical Research Market (US$Billions)  Future Opportunities in biosimilars (US$ Billions) Key ContactsMarket Research on Indian Pharmaceutical @IRR 4This profile is a licensed product and is not to be photocopied
  5. 5. LIST OF TABLES AND FIGURES List of Tables: Table 1: Growth drivers — government support Table 2: launch of patented molecules Table 3: Leading Indian Key players by sales (US$ million) Table 4: Leading foreign Key players by sales (US$ million) Table 5: M&A scenario _ Cumulative FDI inflow (November 2000 – October 2010) Table 6: Investments Key Deals Table 7: Scopes – Research and development List of Figures: Figure 1: Advantage India Figure 2: Market size of the Indian pharmaceutical industry Figure 3: Pharmaceuticals_Market segments Figure 4: Exports of pharmaceutical products Figure 5: US FDA-approved plants Figure 6: Percentage overall indexed manufacturing cost (US FDA-approved plants) Figure 7: Global generics market Figure 8: Location of pharmaceutical SEZs in India Figure 9: Strategy and Regulatory outline (Central Government & State Government) Figure 10: Percentage increase in outsourcing activities Figure 11: Market size forecast for Indian clinical research market (US$ million) Figure 12: Future opportunity in biosimilars (US$ billion)Market Research on Indian Pharmaceutical @IRR 5This profile is a licensed product and is not to be photocopied
  6. 6. Report Summary: Report Title: MARKET RESEARCH ON PHARMACEUTICALS IN INDIA Reference code: IRRMRRMAR11-03 Published On: 15Mar2011 Published by: IRR [International Research Report] Pages: 35 pages Price: 50USD Contact Us Email us: / Website: Contact No: +91- 9840995095/ +91-(44)-45504412Market Research on Indian Pharmaceutical @IRR 6This profile is a licensed product and is not to be photocopied